Key Developments: Medifast Inc (MED)

MED on New York Consolidated

33.44USD
15 Sep 2014
Price Change (% chg)

$0.47 (+1.43%)
Prev Close
$32.97
Open
$32.97
Day's High
$33.69
Day's Low
$32.60
Volume
158,785
Avg. Vol
228,448
52-wk High
$36.06
52-wk Low
$23.02

Search Stocks

Latest Key Developments (Source: Significant Developments)

Medifast Inc gives Q3 2014 outlook below analysts' estimates; lowers FY 2014 revenue outlook; lowers high end of prior FY 2014 ESP outlook to a range in line with analysts' estimates
Thursday, 7 Aug 2014 04:14pm EDT 

Medifast Inc:Expects Q3 2014 net revenue to be in the range of $75 to $78 mln.Expects Q3 2014 earnings per diluted share to be in the range of $0.35 to $0.37.Expects FY 2014 revenue to be in the range of $320 to $330 mln.Expects FY 2014 earnings per diluted share in the range of $1.80 to $1.85.Q3 2014 revenue of $91 mln, EPS of $0.54 - Thomson Reuters I/B/E/S.FY 2014 revenue of $344 mln, EPS of $1.83 - Thomson Reuters I/B/E/S.  Full Article

Medifast Inc gives Q2 2014 guidance below analysts' estimates; reiterates FY 2014 guidance
Monday, 5 May 2014 04:05pm EDT 

Medifast Inc:Expects Q2 2014 net revenue to be in range of about $85 mln to $88 mln.Expects Q2 2014 earnings per diluted share (EPS) to be in range of $0.37 to $0.40.Reiterates FY 2014 guidance of net revenue to be in range of $340 mln to $380 mln and earnings per diluted share in range of $1.80 to $1.90.Q2 2014 revenue of $96 mln and EPS of $0.55 - Thomson Reuters I/B/E/S.FY 2014 revenue of $354 mln and EPS of $1.84 - Thomson Reuters I/B/E/S.  Full Article

Medifast updates Q1 2014 revenue guidance; raises Q1 2014 EPS guidance; reaffirms FY 2014 guidance
Tuesday, 22 Apr 2014 08:00am EDT 

Medifast Inc:Says Q1 2014 net revenue will fall within the previously announced range of $86 to $88 million and earnings per diluted share will exceed the guidance of $0.32 to $0.35.Reiterates FY 2014 guidance for net revenue in the range of $340 to $380 million and earnings per diluted share in the range of $1.80 to $1.90.Q1 2014 revenue of $88 million and EPS of $0.35 - Thomson Reuters I/B/E/S.FY 2014 revenue of $356 million and EPS of $1.83 - Thomson Reuters I/B/E/S.  Full Article

Medifast Inc gives Q1 2014 guidance below analysts' estimates; gives FY 2014 guidance; EPS guidance below analysts' estimates
Monday, 10 Mar 2014 04:05pm EDT 

Medifast Inc:Expects Q1 2014 net revenue of $86 to $88 million.Expects Q1 2014 earnings per diluted share of $0.32 to $0.35.Expects FY 2014 net revenue of $340 to $380 million.Expects FY 2014 earnings per diluted share of $1.80 to $1.90.Q1 2014 revenue of $97 million and EPS of $0.49 - Thomson Reuters I/B/E/S.FY 2014 revenue of $373 million and EPS of $1.93 - Thomson Reuters I/B/E/S.  Full Article

Medifast Inc Issues FY 2013 Revenue Guidance Below Analysts' Estimates; Lowers High End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates
Tuesday, 5 Nov 2013 04:05pm EST 

Medifast Inc announced that for fiscal 2013, it expects net revenue in the range of $360 million to $365 million and narrowed its earnings per share guidance to $1.70 to 1.75. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $377 million and EPS of $1.72 for fiscal 2013.  Full Article

Medifast Inc Reaffirms FY 2013 EPS Guidance-Conference Call
Thursday, 19 Sep 2013 03:45pm EDT 

Medifast Inc announced that guidance for fiscal 2013 is to profit about $1.70 to $1.80 a share. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $1.72 for fiscal 2013.  Full Article

Medifast Inc Issues Q3 2013 Guidance Below Analysts' Estimates; Lowers FY 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance
Tuesday, 6 Aug 2013 04:05pm EDT 

Medifast Inc announced that for the third quarter of 2013, it expects net revenue to be in the range of approximately $93 to $96 million, Earnings per diluted share (EPS) to be in the range of $0.38 to $0.42 and net income would have been $5.8 million, or $0.42 per diluted share. For fiscal 2013, the Company narrowed net revenue guidance to $375 to $385 million and maintained its earnings per share guidance of $1.70 to $1.80. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $100 million and EPS of $0.53 for the third quarter of 2013; revenue of $388 million and EPS of $1.79 for fiscal 2013.  Full Article

Medifast Inc Q2 2013 Guidance Below Analysts' Estimates; Reiterates FY 2013 Guidance
Wednesday, 8 May 2013 04:06pm EDT 

Medifast Inc announced that for the second quarter of 2013, it expects net revenue to be in the range of $98.0 to $102.0 million and earnings per diluted share (EPS) to be in the range of $0.45 to $0.50. For fiscal 2013, the Company reiterated its previous guidance of net revenue to be in the range of $385 to $400 million and EPS in the range of $1.70 to $1.80. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $102.8 million and EPS of $0.55 for the second quarter of 2013; revenue of $389 million and EPS of $1.77 for fiscal 2013.  Full Article

Medifast Inc Announces Favorable Resolution Of Securities Class Action Lawsuit
Monday, 1 Apr 2013 04:30pm EDT 

Medifast Inc announced the favorable resolution of a securities class action lawsuit initiated in March, 2011. Maryland U.S. District Judge George L. Russell III said he agreed with Medifast's argument that the financial restatements in March, 2010 due to discovered errors in its tax calculations were the result of rapid growth and a transition to a new auditing team.  Full Article

Medifast Inc Issues Q1 2013 Guidance Below Analysts' Estimates; Issues FY 2013 Guidance In Line With Analysts' Estimates
Thursday, 7 Mar 2013 04:05pm EST 

Medifast Inc announced that for the first quarter of 2013, it expects net revenue to be in the range of $93 to $95 million and earnings per diluted share (EPS) to be in the range of $0.32 to $0.35. For fiscal 2013, it expects net revenue to be in the range of $385 to $400 million and earnings per diluted share (EPS) to be in the range of $1.70 to $1.80. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $101 million and EPS of $0.45 for the first quarter of 2013; revenue of $400 million and EPS of $1.76 for fiscal 2013.  Full Article

Search Stocks